3TC

4-AMINO-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]PYRIMIDIN-2(1H)-ONE

Find entries where: 3TC

is present as a standalone ligand in 1 entries

Find related ligands:

Chemical Component Summary
Name	4-AMINO-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]PYRIMIDIN-2(1H)-ONE
Synonyms	(-)-L-2',3'-DIDEOXY-3'-THIACYTIDINE; LAMIVUDINE; EPIVIR
Identifiers	4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
Formula	C₈ H₁₁ N₃ O₃ S
Molecular Weight	229.256
Type	NON-POLYMER
Isomeric SMILES	C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N
InChI	InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1
InChIKey	JTEGQNOMFQHVDC-NKWVEPMBSA-N

Chemical Details
Formal Charge	0
Atom Count	26
Chiral Atom Count	2
Bond Count	27
Aromatic Bond Count	6

Drug Info: DrugBank

DrugBank ID	DB00709
Name	Lamivudine
Groups	approved investigational
Description	A reverse transcriptase inhibitor and zalcitabine analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat Human Immunodeficiency Virus Type 1 (HIV-1) and hepatitis B (HBV).
Synonyms	3'-Thia-2',3'-dideoxycytidine 2',3'-Dideoxy-3'-thiacytidine beta-L-2',3'-Dideoxy-3'-thiacytidine (-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine Lamivudinum Lamivudina Lamivudin (-)-2'-Deoxy-3'-thiacytidine beta-L-3'-Thia-2',3'-dideoxycytidine 3TC Lamivudine
Brand Names	Temixys Abacavir and lamivudine Apo-abacavir-lamivudine-zidovudine Auro-abacavir/lamivudine Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Epzicom 3tc Auro-lamivudine/zidovudine Mint-abacavir/lamivudine Jamp Lamivudine Combivir Lamivudine and Zidovudine Lamivudine/zidovudine Teva Triumeq PD Epivir Kivexa Lamivudine Zidovudine Triumeq Epivir Hbv Symfi Lo Cimduo Abacavir Sulfate, Lamivudine and Zidovudine Lamivudine Teva Pharma B.V. Abacavir and Lamivudine Apo-lamivudine-zidovudine Zeffix Dutrebis Mylan-abacavir/lamivudine Apo-abacavir-lamivudine Tablets LAMIVUDINE and ZIDOVUDINE Symfi Lamivudine Teva Teva-lamivudine/zidovudine Trizivir Apo-abacavir-lamivudine Jamp Abacavir / Lamivudine PMS-abacavir-lamivudine Teva-abacavir/lamivudine Auro-lamivudine Delstrigo Jamp Lamivudine / Zidovudine Lamivudine, Nevirapine, and Zidovudine Jamp Lamivudine Hbv Lamivudine Oral Solution Apo-zidovudine-lamivudine-nevirapine Apo-lamivudine Apo-lamivudine Hbv Lamivudine Dovato Abacavir, Lamivudine and Zidovudine Heptovir
Indication	For the treatment of HIV infection and chronic hepatitis B (HBV).
Categories	Agents Causing Muscle Toxicity Anti-HIV Agents Anti-Infective Agents Anti-Retroviral Agents Antiinfectives for Systemic Use Antiviral Agents Antivirals for Systemic Use Antivirals used in combination for the treatment of HIV infections BCRP/ABCG2 Substrates Deoxycytidine Deoxyribonucleosides Dideoxynucleosides Direct Acting Antivirals Drugs that are Mainly Renally Excreted Enzyme Inhibitors Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor Nucleic Acid Synthesis Inhibitors Nucleic Acids, Nucleotides, and Nucleosides Nucleoside and Nucleotide Reverse Transcriptase Inhibitors Nucleoside Reverse Transcriptase Inhibitors Nucleosides OAT1/SLC22A6 Substrates OCT1 substrates OCT2 Substrates P-glycoprotein substrates Pyrimidine Nucleosides Pyrimidines Reverse Transcriptase Inhibitors
ATC-Code	J05AR27 J05AR02 J05AR25 J05AR11 J05AR07 J05AR01 J05AR13 J05AR12 J05AR24 J05AR04 J05AR16 J05AR05 J05AF05
CAS number	134678-17-4

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Reverse transcriptase/RNaseH	PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKI...	unknown	inhibitor
DNA	-	unknown	binder
Protein P	MPLSYPHFRKLLLLDDEAGPLEEELPRLADEDLNRRVAADLNLQLPNVSI...	unknown	inhibitor
Deoxycytidine kinase	MATPPKRSCPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLCEDWEV...	unknown	substrate
UMP-CMP kinase	MKPLVVFVLGGPGAGKGTQCARIVEKYGYTHLSAGELLRDERKNPDSQYG...	unknown	substrate
Phosphoglycerate kinase 1	MSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFC...	unknown	substrate
Nucleoside diphosphate kinase A	MANCERTFIAIKPDGVQRGLVGEIIKRFEQKGFRLVGLKFMQASEDLLKE...	unknown	substrate
Nucleoside diphosphate kinase B	MANLERTFIAIKPDGVQRGLVGEIIKRFEQKGFRLVAMKFLRASEEHLKQ...	unknown	substrate
Choline-phosphate cytidylyltransferase A	MDAQCSAKVNARKRRKEAPGPNGATEEDGVPSKVQRCAVGLRQPAPFSDE...	unknown	substrate
Ethanolamine-phosphate cytidylyltransferase	MIRNGRGAAGGAEQPGPGGRRAVRVWCDGCYDMVHYGHSNQLRQARAMGD...	unknown	substrate
5'(3')-deoxyribonucleotidase, cytosolic type	MARSVRVLVDMDGVLADFEAGLLRGFRRRFPEEPHVPLEQRRGFLAREQY...	unknown	substrate
Serum albumin	MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...	unknown
Multidrug resistance-associated protein 1	MALRGFCSADGSDPLWDWNVTWNTSNPDFTKCFQNTVLVWVPCFYLWACF...	unknown	inhibitor
Solute carrier family 22 member 6	MAFNDLLQQVGGVGRFQQIQVTLVVLPLLLMASHNTLQNFTAAIPTHHCR...	unknown	substrate
ATP-binding cassette sub-family G member 2	MSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKS...	unknown	substrate
Solute carrier family 22 member 1	MPTVDDILEQVGESGWFQKQAFLILCLLSAAFAPICVGIVFLGFTPDHHC...	unknown	substrate
Solute carrier family 22 member 2	MPTTVDDVLEHGGEFHFFQKQMFFLLALLSATFAPIYVGIVFLGFTPDHR...	unknown	substrate
Solute carrier family 22 member 3	MPSFDEALQRVGEFGRFQRRVFLLLCLTGVTFAFLFVGVVFLGTQPDHYW...	unknown	substrate
P-glycoprotein 1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown	substrate
Multidrug resistance-associated protein 4	MLPVYQEVKPNPLQDANLCSRVFFWWLNPLFKIGHKRRLEEDDMYSVLPE...	unknown	substrate
Canalicular multispecific organic anion transporter 2	MDALCGSGELGSKFWDSNLSVHTENPDLTPCFQNSLLAWVPCIYLWVALP...	unknown	substrate
Canalicular multispecific organic anion transporter 1	MLEKFCNSTFWNSSFLDSPEADLPLCFEQTVLVWIPLGYLWLLAPWQLLH...	unknown
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682